id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02441140 | 1:31:treatment,35:47:treatment,71:88:treatment | Prior bilateral tubal ligation or hysterectomy (as this would prevent chromopertubation) | 2 | [
"Prior",
"bilateral",
"tubal",
"ligation",
"or",
"hysterectomy",
"(",
"as",
"this",
"would",
"prevent",
"chromopertubation",
")"
] | [
1,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
1,
0
] |
NCT02507011 | 1:7:chronic_disease | Asthma | 2 | [
"Asthma"
] | [
2
] |
NCT01941316 | 21:37:cancer,87:103:cancer,128:137:treatment,153:155:treatment,159:175:treatment,,227:249:treatment | Patients with known brain metastases are eligible only if he/she has been treated for brain metastasis, are asymptomatic after treatment, have a stable CT or MRI of the brain within 28 days of enrollment and are not receiving corticosteroid therapy to control symptoms from brain metastasis | 2 | [
"Patients",
"with",
"known",
"brain",
"metastases",
"are",
"eligible",
"only",
"if",
"he/she",
"has",
"been",
"treated",
"for",
"brain",
"metastasis",
",",
"are",
"asymptomatic",
"after",
"treatment",
",",
"have",
"a",
"stable",
"CT",
"or",
"MRI",
"of",
"the... | [
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02365090 | 1:14:chronic_disease,32:43:chronic_disease,37:43:chronic_disease,54:77:chronic_disease | Anisometropic (with or without microtropia) or fully accommodative esotropia (no tropia present with glasses), | 2 | [
"Anisometropic",
"(",
"with",
"or",
"without",
"microtropia",
")",
"or",
"fully",
"accommodative",
"esotropia",
"(",
"no",
"tropia",
"present",
"with",
"glasses",
")",
","
] | [
2,
0,
0,
0,
0,
2,
0,
0,
0,
2,
2,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02352480 | 35:51:allergy_name,53:69:allergy_name,71:79:allergy_name,81:94:allergy_name,103:129:allergy_name | Subjects known to be sensitive to Aurix components (calcium chloride, thrombin, ascorbic acid) and/or materials of bovine origin | 2 | [
"Subjects",
"known",
"to",
"be",
"sensitive",
"to",
"Aurix",
"components",
"(",
"calcium",
"chloride",
",",
"thrombin",
",",
"ascorbic",
"acid",
")",
"and/or",
"materials",
"of",
"bovine",
"origin"
] | [
0,
0,
0,
0,
0,
0,
4,
4,
0,
4,
4,
0,
4,
0,
4,
4,
0,
0,
4,
4,
4,
4
] |
NCT02588326 | 1:15:chronic_disease | ear infections | 2 | [
"ear",
"infections"
] | [
2,
2
] |
NCT02187198 | 44:55:chronic_disease,65:76:chronic_disease,84:98:chronic_disease,100:105:chronic_disease,107:116:chronic_disease,121:138:chronic_disease,149:172:treatment | serious unstable medical illness including bradycardia or other arrhythmias, major cardiovascular, renal, endocrine, or hepatic disorders for which buprenorphine treatment is contraindicated or which at the determination of the MD is medically dangerous | 2 | [
"serious",
"unstable",
"medical",
"illness",
"including",
"bradycardia",
"or",
"other",
"arrhythmias",
",",
"major",
"cardiovascular",
",",
"renal",
",",
"endocrine",
",",
"or",
"hepatic",
"disorders",
"for",
"which",
"buprenorphine",
"treatment",
"is",
"contraindic... | [
0,
0,
0,
0,
0,
2,
0,
0,
2,
0,
0,
2,
0,
2,
0,
2,
0,
0,
2,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00085982 | 7:20:chronic_disease | Known HIV infection | 2 | [
"Known",
"HIV",
"infection"
] | [
0,
2,
2
] |
NCT02532452 | 40:48:treatment,40:47:treatment,,63:73:treatment | Clinical status must allow tapering of steroids to < 0.5mg/kg prednisone or other steroid equivalent | 2 | [
"Clinical",
"status",
"must",
"allow",
"tapering",
"of",
"steroids",
"to",
"<",
"0.5mg/kg",
"prednisone",
"or",
"other",
"steroid",
"equivalent"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
0,
1,
0
] |
NCT02511301 | 33:40:cancer | Any biopsy or treatment for the BI-RADS category 4 or 5 abnormality | 2 | [
"Any",
"biopsy",
"or",
"treatment",
"for",
"the",
"BI-RADS",
"category",
"4",
"or",
"5",
"abnormality"
] | [
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02876302 | 16:27:treatment | The effects of ruxolitinib on the developing human fetus are unknown | 2 | [
"The",
"effects",
"of",
"ruxolitinib",
"on",
"the",
"developing",
"human",
"fetus",
"are",
"unknown"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01438073 | 17:32:chronic_disease,34:43:chronic_disease,47:51:chronic_disease | no evidence for androgen excess (hirsutism or acne) | 2 | [
"no",
"evidence",
"for",
"androgen",
"excess",
"(",
"hirsutism",
"or",
"acne",
")"
] | [
0,
0,
0,
2,
2,
0,
2,
0,
2,
0
] |
NCT02323126 | 1:13:cancer, | Tumor tissue for determination and/or confirmation of genetic pre-requisites (i.e. EGFR T790M positivity post progression on EGFR TKI for Group 1; cMet status for Group 2) must be provided for analysis | 2 | [
"Tumor",
"tissue",
"for",
"determination",
"and/or",
"confirmation",
"of",
"genetic",
"pre-requisites",
"(",
"i.e",
".",
"EGFR",
"T790M",
"positivity",
"post",
"progression",
"on",
"EGFR",
"TKI",
"for",
"Group",
"1",
";",
"cMet",
"status",
"for",
"Group",
"2",... | [
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01898793 | 16:31:treatment,46:76:treatment,,152:165:treatment | Able to be off corticosteroids and any other immune suppressive medications beginning on Day -3 and continuing until 30 days after the infusion of the CIML NK cells | 2 | [
"Able",
"to",
"be",
"off",
"corticosteroids",
"and",
"any",
"other",
"immune",
"suppressive",
"medications",
"beginning",
"on",
"Day",
"-3",
"and",
"continuing",
"until",
"30",
"days",
"after",
"the",
"infusion",
"of",
"the",
"CIML",
"NK",
"cells"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01652092 | 1:19:chronic_disease | Griscelli Syndrome | 2 | [
"Griscelli",
"Syndrome"
] | [
2,
2
] |
NCT02995590 | 15:27:chronic_disease | No history of lung disease | 2 | [
"No",
"history",
"of",
"lung",
"disease"
] | [
0,
0,
0,
2,
2
] |
NCT02394028 | 28:46:allergy_name,134:136:allergy_name,140:150:allergy_name | intolerance to one or more anti-TNF therapies are eligible to participate in the study provided they are intolerant or refractory to CS or IS therapy | 2 | [
"intolerance",
"to",
"one",
"or",
"more",
"anti-TNF",
"therapies",
"are",
"eligible",
"to",
"participate",
"in",
"the",
"study",
"provided",
"they",
"are",
"intolerant",
"or",
"refractory",
"to",
"CS",
"or",
"IS",
"therapy"
] | [
0,
0,
0,
0,
0,
4,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
4,
4
] |
NCT02008656 | 1:24:cancer | Recurrent rectal cancer | 2 | [
"Recurrent",
"rectal",
"cancer"
] | [
3,
3,
3
] |
NCT02464436 | 1:17:treatment,38:52:treatment,,236:245:treatment | Cataract surgery in the study eye or ocular surgery in either eye (which in the opinion of the investigator may have an impact on patient safety or the integrity of data from the study eye) during the study or within 3 months prior to treatment | 2 | [
"Cataract",
"surgery",
"in",
"the",
"study",
"eye",
"or",
"ocular",
"surgery",
"in",
"either",
"eye",
"(",
"which",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
"may",
"have",
"an",
"impact",
"on",
"patient",
"safety",
"or",
"the",
"integrity",
"of... | [
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02464436 | 1:12:chronic_disease,, | High myopia (>6 diopters) in the study eye | 2 | [
"High",
"myopia",
"(",
">",
"6",
"diopters",
")",
"in",
"the",
"study",
"eye"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02121158 | 68:94:treatment | Clinical symptoms or findings that would make them a candidate for coronary revascularization | 2 | [
"Clinical",
"symptoms",
"or",
"findings",
"that",
"would",
"make",
"them",
"a",
"candidate",
"for",
"coronary",
"revascularization"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01589263 | 1:23:chronic_disease,25:35:chronic_disease,37:75:chronic_disease,80:98:chronic_disease | Eaton-Lambert syndrome, hemophilia, hereditary clotting factors deficiency, or bleeding diathesis | 2 | [
"Eaton-Lambert",
"syndrome",
",",
"hemophilia",
",",
"hereditary",
"clotting",
"factors",
"deficiency",
",",
"or",
"bleeding",
"diathesis"
] | [
2,
2,
0,
2,
0,
2,
2,
2,
2,
0,
0,
2,
2
] |
NCT02401347 | 5:23:chronic_disease | Non-measurable disease only | 2 | [
"Non-measurable",
"disease",
"only"
] | [
2,
2,
0
] |
NCT02440581 | 1:31:chronic_disease,72:81:chronic_disease,85:94:chronic_disease | Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia | 2 | [
"Abnormalities",
"of",
"the",
"esophagus",
"which",
"delay",
"esophageal",
"emptying",
"such",
"as",
"stricture",
"or",
"achalasia"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
0,
2
] |
NCT02610374 | 29:34:chronic_disease | Documentation of a negative HIV-1 antibody test | 2 | [
"Documentation",
"of",
"a",
"negative",
"HIV-1",
"antibody",
"test"
] | [
0,
0,
0,
0,
2,
0,
0
] |
NCT02047474 | 23:35:treatment,,54:66:cancer,78:95:cancer | Patients who received chemotherapy > 5 years ago for malignancies other than pancreatic cancer are eligible | 2 | [
"Patients",
"who",
"received",
"chemotherapy",
">",
"5",
"years",
"ago",
"for",
"malignancies",
"other",
"than",
"pancreatic",
"cancer",
"are",
"eligible"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
3,
0,
0,
3,
3,
0,
0
] |
NCT02622295 | 1:18:chronic_disease | Bleeding disorder | 2 | [
"Bleeding",
"disorder"
] | [
2,
2
] |
NCT03067818 | 1:31:chronic_disease | Brainstem or cerebellar stroke | 2 | [
"Brainstem",
"or",
"cerebellar",
"stroke"
] | [
2,
2,
2,
2
] |
NCT02105545 | 30:44:cancer | Subjects for whom sufficient cancer tissues are not available to meet the objectives of the study | 2 | [
"Subjects",
"for",
"whom",
"sufficient",
"cancer",
"tissues",
"are",
"not",
"available",
"to",
"meet",
"the",
"objectives",
"of",
"the",
"study"
] | [
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00919503 | 33:50:treatment,54:71:treatment,76:89:treatment | DONOR: Deemed unable to undergo marrow harvesting or PBSC mobilization and leukapheresis | 2 | [
"DONOR",
":",
"Deemed",
"unable",
"to",
"undergo",
"marrow",
"harvesting",
"or",
"PBSC",
"mobilization",
"and",
"leukapheresis"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
1
] |
NCT03181126 | 19:41:chronic_disease | Participants with malabsorption syndrome or any other condition that precludes enteral administration | 2 | [
"Participants",
"with",
"malabsorption",
"syndrome",
"or",
"any",
"other",
"condition",
"that",
"precludes",
"enteral",
"administration"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00065676 | 1:7:chronic_disease | anemia | 2 | [
"anemia"
] | [
2
] |
NCT03166371 | 16:22:cancer,,79:89:cancer,93:128:cancer,132:147:cancer | Current active cancer or recently (within 6 months) treated cancer other than basal cell or squamous cell carcinoma of the skin or prostate cancer | 2 | [
"Current",
"active",
"cancer",
"or",
"recently",
"(",
"within",
"6",
"months",
")",
"treated",
"cancer",
"other",
"than",
"basal",
"cell",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
"or",
"prostate",
"cancer"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
3,
3
] |
NCT02670044 | 14:37:chronic_disease,39:74:chronic_disease,96:99:chronic_disease,101:111:cancer,113:129:chronic_disease,134:163:chronic_disease | Positive for hepatitis C virus (HCV), hepatitis B surface antigen (HBsAg) and known history of HIV, malignancy, active infection and cardiovascular diseases (CVs) | 2 | [
"Positive",
"for",
"hepatitis",
"C",
"virus",
"(",
"HCV",
")",
",",
"hepatitis",
"B",
"surface",
"antigen",
"(",
"HBsAg",
")",
"and",
"known",
"history",
"of",
"HIV",
",",
"malignancy",
",",
"active",
"infection",
"and",
"cardiovascular",
"diseases",
"(",
... | [
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
3,
0,
2,
2,
0,
2,
2,
2,
0,
0
] |
NCT01360606 | 18:25:chronic_disease,27:40:chronic_disease,44:61:chronic_disease | Substance abuse, medical, psychological or social conditions that may interfere with the patient's participation in the study or evaluation of the study results | 2 | [
"Substance",
"abuse",
",",
"medical",
",",
"psychological",
"or",
"social",
"conditions",
"that",
"may",
"interfere",
"with",
"the",
"patient",
"'s",
"participation",
"in",
"the",
"study",
"or",
"evaluation",
"of",
"the",
"study",
"results"
] | [
0,
0,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03084640 | 44:89:cancer | Histopathologically confirmed diagnosis of metastatic or unresectable malignant melanoma | 2 | [
"Histopathologically",
"confirmed",
"diagnosis",
"of",
"metastatic",
"or",
"unresectable",
"malignant",
"melanoma"
] | [
0,
0,
0,
0,
3,
3,
3,
3,
3
] |
NCT02323880 | 51:61:cancer,129:146:cancer,140:145:cancer,148:169:cancer,188:201:cancer | patients must have had histologic verification of malignancy at original diagnosis or relapse except in patients with intrinsic brain stem tumors, optic pathway gliomas, or patients with pineal tumors and elevations of cerebrospinal fluid (CSF) or serum tumor markers including alpha-fetoprotein or beta-human chorionic ... | 2 | [
"patients",
"must",
"have",
"had",
"histologic",
"verification",
"of",
"malignancy",
"at",
"original",
"diagnosis",
"or",
"relapse",
"except",
"in",
"patients",
"with",
"intrinsic",
"brain",
"stem",
"tumors",
",",
"optic",
"pathway",
"gliomas",
",",
"or",
"patie... | [
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
3,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01906385 | 37:109:treatment,122:145:treatment,151:162:treatment,202:224:treatment | Progression following both standard combined modality treatment with radiation and temozolomide chemotherapy, as well as anti-angiogenic therapy (ie, bevacizumab; patients not eligible for or refusing antiangiogenic therapy will also be allowed) | 2 | [
"Progression",
"following",
"both",
"standard",
"combined",
"modality",
"treatment",
"with",
"radiation",
"and",
"temozolomide",
"chemotherapy",
",",
"as",
"well",
"as",
"anti-angiogenic",
"therapy",
"(",
"ie",
",",
"bevacizumab",
";",
"patients",
"not",
"eligible",... | [
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02508038 | 1:4:treatment,9:24:chronic_disease,26:33:treatment | NAT for West Nile Virus (WNV-PCR) | 2 | [
"NAT",
"for",
"West",
"Nile",
"Virus",
"(",
"WNV-PCR",
")"
] | [
1,
0,
2,
2,
2,
0,
1,
0
] |
NCT02442102 | 6:17:treatment,21:50:treatment,66:73:treatment, | Ever tracheotomy or prior endotracheal intubation other than for surgery (≤ 1 year) | 2 | [
"Ever",
"tracheotomy",
"or",
"prior",
"endotracheal",
"intubation",
"other",
"than",
"for",
"surgery",
"(",
"≤",
"1",
"year",
")"
] | [
0,
1,
0,
1,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02561104 | 101:117:treatment | Study doctor will assess patient findings and determine how long RGP lens wear must be discontinued prior to surgery | 2 | [
"Study",
"doctor",
"will",
"assess",
"patient",
"findings",
"and",
"determine",
"how",
"long",
"RGP",
"lens",
"wear",
"must",
"be",
"discontinued",
"prior",
"to",
"surgery"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02233868 | 18:29:treatment | chronically used medications are exclusionary from the study | 2 | [
"chronically",
"used",
"medications",
"are",
"exclusionary",
"from",
"the",
"study"
] | [
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT03125226 | 1:17:treatment | Prior cystectomy | 2 | [
"Prior",
"cystectomy"
] | [
1,
1
] |
NCT02109627 | 23:44:treatment,48:58:treatment,60:68:treatment,72:98:treatment, | Prior exposure to the investigational agent or anti-c-Met, anti-HGF or anti-VEGF directed therapy within six months prior to study entry | 2 | [
"Prior",
"exposure",
"to",
"the",
"investigational",
"agent",
"or",
"anti-c-Met",
",",
"anti-HGF",
"or",
"anti-VEGF",
"directed",
"therapy",
"within",
"six",
"months",
"prior",
"to",
"study",
"entry"
] | [
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02165449 | 15:43:treatment, | No changes in antidepressant medication(s) in the past one (1) month | 2 | [
"No",
"changes",
"in",
"antidepressant",
"medication",
"(",
"s",
")",
"in",
"the",
"past",
"one",
"(",
"1",
")",
"month"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03017937 | 17:38:chronic_disease | Known increased intracranial pressure | 2 | [
"Known",
"increased",
"intracranial",
"pressure"
] | [
0,
0,
2,
2
] |
NCT01543490 | 13:24:chronic_disease | symptomatic blepharitis | 2 | [
"symptomatic",
"blepharitis"
] | [
0,
2
] |
NCT02548104 | 1:16:treatment | revision of TKA | 2 | [
"revision",
"of",
"TKA"
] | [
1,
1,
1
] |
NCT02107703 | 13:22:chronic_disease,26:42:chronic_disease,58:73:chronic_disease | Have active bacterial or fungal infection, or detectable viral infection | 2 | [
"Have",
"active",
"bacterial",
"or",
"fungal",
"infection",
",",
"or",
"detectable",
"viral",
"infection"
] | [
0,
0,
2,
0,
2,
2,
0,
0,
0,
2,
2
] |
NCT02201992 | 34:61:treatment,65:82:treatment,,,120:129:treatment,134:146:treatment | Patients must have completed any prior adjuvant chemotherapy or radiation therapy 2 or more weeks (6 or more weeks for mitomycin and nitrosoureas) prior to randomization and be adequately recovered at the time of randomization | 2 | [
"Patients",
"must",
"have",
"completed",
"any",
"prior",
"adjuvant",
"chemotherapy",
"or",
"radiation",
"therapy",
"2",
"or",
"more",
"weeks",
"(",
"6",
"or",
"more",
"weeks",
"for",
"mitomycin",
"and",
"nitrosoureas",
")",
"prior",
"to",
"randomization",
"and... | [
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02584647 | 38:60:treatment | Patients who are receiving any other investigational agents concurrently | 2 | [
"Patients",
"who",
"are",
"receiving",
"any",
"other",
"investigational",
"agents",
"concurrently"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT02525029 | 16:26:chronic_disease,,44:68:treatment,,89:99:treatment | Progression of acute GVHD within 3 days of systemic corticosteroids of at least 2 mg/kg prednisone or equivalent | 2 | [
"Progression",
"of",
"acute",
"GVHD",
"within",
"3",
"days",
"of",
"systemic",
"corticosteroids",
"of",
"at",
"least",
"2",
"mg/kg",
"prednisone",
"or",
"equivalent"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT02250534 | 18:44:treatment | Currently taking anticonvulsant medications | 2 | [
"Currently",
"taking",
"anticonvulsant",
"medications"
] | [
0,
0,
1,
1
] |
NCT03150004 | 70:117:treatment | In first or subsequent relapse or refractory status, with or without prior hematopoietic stem cell transplant (HSCT) | 2 | [
"In",
"first",
"or",
"subsequent",
"relapse",
"or",
"refractory",
"status",
",",
"with",
"or",
"without",
"prior",
"hematopoietic",
"stem",
"cell",
"transplant",
"(",
"HSCT",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0
] |
NCT03068780 | 1:20:chronic_disease | junctional EB (JEB) | 2 | [
"junctional",
"EB",
"(",
"JEB",
")"
] | [
2,
2,
2,
0,
0
] |
NCT02518594 | 13:58:chronic_disease,, | Evidence of severe IUGR (intrauterine growth restriction) (<5th percentile for gestational age) in either fetus | 2 | [
"Evidence",
"of",
"severe",
"IUGR",
"(",
"intrauterine",
"growth",
"restriction",
")",
"(",
"<",
"5th",
"percentile",
"for",
"gestational",
"age",
")",
"in",
"either",
"fetus"
] | [
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02801136 | 7:28:chronic_disease | Other serious mental health diagnoses | 2 | [
"Other",
"serious",
"mental",
"health",
"diagnoses"
] | [
0,
2,
2,
2,
0
] |
NCT02664909 | 8:16:treatment,18:28:treatment,30:41:treatment,43:51:treatment,57:76:treatment | taking Warfarin, Dabigatran, Rivaroxaban, Apixaban, and Fresh Frozen Plasma | 2 | [
"taking",
"Warfarin",
",",
"Dabigatran",
",",
"Rivaroxaban",
",",
"Apixaban",
",",
"and",
"Fresh",
"Frozen",
"Plasma"
] | [
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
1,
1
] |
NCT02459119 | 1:24:treatment,117:129:treatment,,293:312:chronic_disease | Prior radiation therapy is allowed as long as the irradiated area was not the sole source of measurable disease and radiotherapy was completed with recovery from toxicity, at least three weeks prior to enrollment. If the irradiated area is the only site of disease, there must be evidence of progressive disease | 2 | [
"Prior",
"radiation",
"therapy",
"is",
"allowed",
"as",
"long",
"as",
"the",
"irradiated",
"area",
"was",
"not",
"the",
"sole",
"source",
"of",
"measurable",
"disease",
"and",
"radiotherapy",
"was",
"completed",
"with",
"recovery",
"from",
"toxicity",
",",
"at... | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT03111121 | 1:18:treatment | Microlaryngoscopy | 2 | [
"Microlaryngoscopy"
] | [
1
] |
NCT03114501 | ,38:40:treatment, | going to receive at least 4 weeks of RT with at least 20 fractions | 2 | [
"going",
"to",
"receive",
"at",
"least",
"4",
"weeks",
"of",
"RT",
"with",
"at",
"least",
"20",
"fractions"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT01972919 | 20:36:treatment | Ability to swallow oral medications | 2 | [
"Ability",
"to",
"swallow",
"oral",
"medications"
] | [
0,
0,
0,
1,
1
] |
NCT02516696 | 17:38:chronic_disease,,,,,132:145:chronic_disease,,,190:209:chronic_disease,231:254:chronic_disease,295:303:chronic_disease | Subject has had myocardial infarction within 6 months prior to enrollment , or NYHA(New York Hospital Association) Class III or IV heart failure (see APPENDIX VI), Ejection Fraction < 35%, uncontrolled angina, severe uncontrolled ventricular arrhythmias, electrocardiographic evidence of acute ischemia or active conduct... | 2 | [
"Subject",
"has",
"had",
"myocardial",
"infarction",
"within",
"6",
"months",
"prior",
"to",
"enrollment",
",",
"or",
"NYHA",
"(",
"New",
"York",
"Hospital",
"Association",
")",
"Class",
"III",
"or",
"IV",
"heart",
"failure",
"(",
"see",
"APPENDIX",
"VI",
... | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT01895881 | 20:48:cancer | Known or suspected estrogen-dependent neoplasia | 2 | [
"Known",
"or",
"suspected",
"estrogen-dependent",
"neoplasia"
] | [
0,
0,
0,
3,
3
] |
NCT02340156 | 1:11:treatment | Urinalysis: No clinically significant abnormalities | 2 | [
"Urinalysis",
":",
"No",
"clinically",
"significant",
"abnormalities"
] | [
1,
0,
0,
0,
0,
0
] |
NCT02341209 | ,93:115:treatment,, | WOCBP includes any female who has experienced menarche and who has not undergone successful surgical sterilization or is not postmenopausal (defined as amenorrhea ≥ 12 consecutive months without an alternative medical cause) | 2 | [
"WOCBP",
"includes",
"any",
"female",
"who",
"has",
"experienced",
"menarche",
"and",
"who",
"has",
"not",
"undergone",
"successful",
"surgical",
"sterilization",
"or",
"is",
"not",
"postmenopausal",
"(",
"defined",
"as",
"amenorrhea",
"≥",
"12",
"consecutive",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01882153 | 111:128:chronic_disease | Receiving or will receive a parent delivered intervention to alleviate symptoms related to their diagnosis of autistic disorder | 2 | [
"Receiving",
"or",
"will",
"receive",
"a",
"parent",
"delivered",
"intervention",
"to",
"alleviate",
"symptoms",
"related",
"to",
"their",
"diagnosis",
"of",
"autistic",
"disorder"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT01530958 | 1:19:chronic_disease | impaired cognition | 2 | [
"impaired",
"cognition"
] | [
2,
2
] |
NCT01742182 | 14:27:chronic_disease | Diagnosis of idiopathic PD as defined by the United Kingdom PD Society Brain Bank Criteria | 2 | [
"Diagnosis",
"of",
"idiopathic",
"PD",
"as",
"defined",
"by",
"the",
"United",
"Kingdom",
"PD",
"Society",
"Brain",
"Bank",
"Criteria"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02556606 | ,80:95:treatment | Participants have not responded to two or more adequate trials of FDA-approved antidepressants, determined by Antidepressant Treatment Response Questionnaire (ATRQ) criteria | 2 | [
"Participants",
"have",
"not",
"responded",
"to",
"two",
"or",
"more",
"adequate",
"trials",
"of",
"FDA-approved",
"antidepressants",
",",
"determined",
"by",
"Antidepressant",
"Treatment",
"Response",
"Questionnaire",
"(",
"ATRQ",
")",
"criteria"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02122185 | 38:60:treatment | patients who are receiving any other investigational agents | 2 | [
"patients",
"who",
"are",
"receiving",
"any",
"other",
"investigational",
"agents"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01626079 | 1:45:chronic_disease,72:86:treatment,109:121:treatment | Chronic Obstructive Pulmonary Disease (COPD) requiring continuous home oxygen therapy or chronic outpatient oral steroid use | 2 | [
"Chronic",
"Obstructive",
"Pulmonary",
"Disease",
"(",
"COPD",
")",
"requiring",
"continuous",
"home",
"oxygen",
"therapy",
"or",
"chronic",
"outpatient",
"oral",
"steroid",
"use"
] | [
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0
] |
NCT02360579 | 1:29:treatment,74:81:cancer,101:104:cancer,112:140:cancer,, | Palliative radiation therapy is permitted so long as it does not involve lesions being selected for TIL, or as target or non-target lesions. Washout is not required if all related toxicities have resolved to ≤ Grade 1 as per CTCAE v4.03 | 2 | [
"Palliative",
"radiation",
"therapy",
"is",
"permitted",
"so",
"long",
"as",
"it",
"does",
"not",
"involve",
"lesions",
"being",
"selected",
"for",
"TIL",
",",
"or",
"as",
"target",
"or",
"non-target",
"lesions",
".",
"Washout",
"is",
"not",
"required",
"if"... | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
3,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03023930 | 18:21:chronic_disease | ED patients with OUD | 2 | [
"ED",
"patients",
"with",
"OUD"
] | [
0,
0,
0,
2
] |
NCT02945800 | 1:21:treatment | Stem Cell Transplant or Rescue: No evidence of active graft vs. host disease and 2 months must have elapsed from the start of protocol therapy since transplant | 2 | [
"Stem",
"Cell",
"Transplant",
"or",
"Rescue",
":",
"No",
"evidence",
"of",
"active",
"graft",
"vs.",
"host",
"disease",
"and",
"2",
"months",
"must",
"have",
"elapsed",
"from",
"the",
"start",
"of",
"protocol",
"therapy",
"since",
"transplant"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02044120 | 44:75:treatment,,126:137:treatment,139:155:treatment,157:167:treatment,169:178:treatment | Patients must have received as a minimum a first line chemotherapy regimen consisting of at least 2 of the following agents: doxorubicin, cyclophosphamide, ifosfamide, etoposide | 2 | [
"Patients",
"must",
"have",
"received",
"as",
"a",
"minimum",
"a",
"first",
"line",
"chemotherapy",
"regimen",
"consisting",
"of",
"at",
"least",
"2",
"of",
"the",
"following",
"agents",
":",
"doxorubicin",
",",
"cyclophosphamide",
",",
"ifosfamide",
",",
"eto... | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1
] |
NCT02262806 | 15:26:treatment | Withdrawal of metreleptin led to marked worsening of metabolic parameters | 2 | [
"Withdrawal",
"of",
"metreleptin",
"led",
"to",
"marked",
"worsening",
"of",
"metabolic",
"parameters"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02563574 | 9:38:chronic_disease | Current major psychiatric disturbance | 2 | [
"Current",
"major",
"psychiatric",
"disturbance"
] | [
0,
2,
2,
2
] |
NCT01624090 | 36:68:chronic_disease | Patients with any of the following pulmonary function abnormalities | 2 | [
"Patients",
"with",
"any",
"of",
"the",
"following",
"pulmonary",
"function",
"abnormalities"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02879136 | 46:67:chronic_disease | Presence of signs and symptoms suggestive of atypical parkinsonism | 2 | [
"Presence",
"of",
"signs",
"and",
"symptoms",
"suggestive",
"of",
"atypical",
"parkinsonism"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02547818 | 1:17:chronic_disease, | Major depressive episode, as described in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) within the past 6 months, which could lead to difficulty complying with the protocol | 2 | [
"Major",
"depressive",
"episode",
",",
"as",
"described",
"in",
"the",
"Diagnostic",
"and",
"Statistical",
"Manual",
"of",
"Mental",
"Disorders",
"(",
"DSM-IV",
")",
"within",
"the",
"past",
"6",
"months",
",",
"which",
"could",
"lead",
"to",
"difficulty",
"... | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02299414 | 21:30:treatment,34:44:treatment,56:72:allergy_name | Contraindication to labetalol or nifedipine (e.g. know hypersensitivity) | 2 | [
"Contraindication",
"to",
"labetalol",
"or",
"nifedipine",
"(",
"e.g",
".",
"know",
"hypersensitivity",
")"
] | [
0,
0,
1,
0,
1,
0,
0,
0,
0,
4,
0
] |
NCT01893307 | 1:53:cancer | Distant Metastases (Stage IV C, any T, any N and M1) | 2 | [
"Distant",
"Metastases",
"(",
"Stage",
"IV",
"C",
",",
"any",
"T",
",",
"any",
"N",
"and",
"M1",
")"
] | [
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0
] |
NCT01532687 | 1:38:treatment | prior to the first dose of study drug and for the duration of the study | 2 | [
"prior",
"to",
"the",
"first",
"dose",
"of",
"study",
"drug",
"and",
"for",
"the",
"duration",
"of",
"the",
"study"
] | [
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02430077 | ,,,78:109:treatment | Hepatic steatosis (>5.6% hepatic triglyceride content) as demonstrated by 1H magnetic resonance spectroscopy | 2 | [
"Hepatic",
"steatosis",
"(",
">",
"5.6",
"%",
"hepatic",
"triglyceride",
"content",
")",
"as",
"demonstrated",
"by",
"1H",
"magnetic",
"resonance",
"spectroscopy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02451423 | 30:36:cancer | Presence of PD-L1 antigen on tumors is NOT required for study entry | 2 | [
"Presence",
"of",
"PD-L1",
"antigen",
"on",
"tumors",
"is",
"NOT",
"required",
"for",
"study",
"entry"
] | [
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0
] |
NCT02317991 | 108:117:treatment,160:191:chronic_disease,193:209:chronic_disease,211:234:chronic_disease,242:264:chronic_disease,304:317:chronic_disease,321:334:chronic_disease | Patients with other concurrent severe and/or uncontrolled medical disease which could compromise safety of treatment as so judged by treating physician (i.e., severely impaired lung function, severe infection, ventricular arrhythmias active ischemic heart disease, known active vasculitis of any cause, chronic liver or ... | 2 | [
"Patients",
"with",
"other",
"concurrent",
"severe",
"and/or",
"uncontrolled",
"medical",
"disease",
"which",
"could",
"compromise",
"safety",
"of",
"treatment",
"as",
"so",
"judged",
"by",
"treating",
"physician",
"(",
"i.e.",
",",
"severely",
"impaired",
"lung",... | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0
] |
NCT01918644 | 23:32:cancer,34:41:cancer,45:60:cancer | Patients with primary ampullary, biliary or duodenal cancer | 2 | [
"Patients",
"with",
"primary",
"ampullary",
",",
"biliary",
"or",
"duodenal",
"cancer"
] | [
0,
0,
0,
3,
0,
3,
0,
3,
3
] |
NCT02706249 | 8:28:chronic_disease | Active peptic ulcer disease | 2 | [
"Active",
"peptic",
"ulcer",
"disease"
] | [
0,
2,
2,
2
] |
NCT02209636 | 12:23:treatment,99:109:treatment,125:138:treatment | Not taking medications that interact with agents administered during experimental sessions (e.g., sildenafil interacts with nitroglycerin) | 2 | [
"Not",
"taking",
"medications",
"that",
"interact",
"with",
"agents",
"administered",
"during",
"experimental",
"sessions",
"(",
"e.g.",
",",
"sildenafil",
"interacts",
"with",
"nitroglycerin",
")"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0
] |
NCT02519543 | 23:26:chronic_disease | alcohol dependence or T2D | 2 | [
"alcohol",
"dependence",
"or",
"T2D"
] | [
0,
0,
0,
2
] |
NCT01966367 | ,,55:73:chronic_disease, | Patient must be < or = 40 years of age. Patients with sickle cell anemia must be at least 2 years of age | 2 | [
"Patient",
"must",
"be",
"<",
"or",
"=",
"40",
"years",
"of",
"age",
".",
"Patients",
"with",
"sickle",
"cell",
"anemia",
"must",
"be",
"at",
"least",
"2",
"years",
"of",
"age"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02734602 | 37:62:chronic_disease | Meet DSM-IV diagnostic criteria for Major Depressive Disorder, and for a current depressive episode | 2 | [
"Meet",
"DSM-IV",
"diagnostic",
"criteria",
"for",
"Major",
"Depressive",
"Disorder",
",",
"and",
"for",
"a",
"current",
"depressive",
"episode"
] | [
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01495637 | 87:96:treatment | DNR status or care team/family is considering plans for withdrawal of life-sustaining therapies | 2 | [
"DNR",
"status",
"or",
"care",
"team/family",
"is",
"considering",
"plans",
"for",
"withdrawal",
"of",
"life-sustaining",
"therapies"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02192398 | 1:12:chronic_disease,,,,,,, | Hypotension (SBP < 90 mmHg and DBP < 60 mmHg for female or SBP < 100 mmHg and DBP < 60 mmHg for male; measured while in a sitting position) will be reviewed by a study physician | 2 | [
"Hypotension",
"(",
"SBP",
"<",
"90",
"mmHg",
"and",
"DBP",
"<",
"60",
"mmHg",
"for",
"female",
"or",
"SBP",
"<",
"100",
"mmHg",
"and",
"DBP",
"<",
"60",
"mmHg",
"for",
"male",
";",
"measured",
"while",
"in",
"a",
"sitting",
"position",
")",
"will",
... | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02991248 | 24:54:chronic_disease,61:82:chronic_disease,86:124:chronic_disease | concomitant central or peripheral neurological injury (e.g. traumatic head injury or peripheral nerve damage in lower limbs) | 2 | [
"concomitant",
"central",
"or",
"peripheral",
"neurological",
"injury",
"(",
"e.g",
".",
"traumatic",
"head",
"injury",
"or",
"peripheral",
"nerve",
"damage",
"in",
"lower",
"limbs",
")"
] | [
0,
0,
0,
2,
2,
2,
2,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02291302 | 17:23:chronic_disease | grades K-8 with asthma attending sampling/intervention schools | 2 | [
"grades",
"K-8",
"with",
"asthma",
"attending",
"sampling/intervention",
"schools"
] | [
0,
0,
0,
2,
0,
0,
0
] |
NCT02520427 | 14:25:chronic_disease | Positive for Hepatitis B | 2 | [
"Positive",
"for",
"Hepatitis",
"B"
] | [
0,
0,
2,
2
] |
NCT00670358 | 28:64:treatment,81:88:treatment,121:132:treatment,140:148:treatment,152:180:treatment | Able to receive concurrent prophylactic anticoagulation therapy (e.g., low-dose aspirin [81 mg] daily or an alternative prophylaxis [e.g., warfarin or low molecular weight heparin]) | 2 | [
"Able",
"to",
"receive",
"concurrent",
"prophylactic",
"anticoagulation",
"therapy",
"(",
"e.g.",
",",
"low-dose",
"aspirin",
"[",
"81",
"mg",
"]",
"daily",
"or",
"an",
"alternative",
"prophylaxis",
"[",
"e.g.",
",",
"warfarin",
"or",
"low",
"molecular",
"weig... | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02249039 | 1:9:chronic_disease | Asphyxia | 2 | [
"Asphyxia"
] | [
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.